CSI will again join forces with the University of California, San Francisco to provide a meeting that will give attendees a comprehensive overview of major topics in catheter and device therapy for structural and valvular heart disease, in addition to novel therapies for atrial fibrillation and heart failure. There will also be sessions on catheter therapy for congenital heart disease in adults and innovation. The program will include lectures from leading experts in the field, case presentations with panel discussions, live and recorded cases, a review of ongoing and future studies and training sessions.

The congress is designed for interventional cardiologists, cardiothoracic surgeons, anesthesiologists, EP specialists, imaging specialists, nurses, technicians and any other medical specialty involved in these procedures. With a focus on innovation we will also welcome device companies, engineers, start-ups and venture capitalists.